← Back to Clinical Trials
Recruiting NCT03594318

NCT03594318 Versailles Hospital Cardiac Arrest Registry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03594318
Status Recruiting
Phase
Sponsor Versailles Hospital
Condition Cardiac Arrest
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2006-01
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2006-01 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Out-of-hospital and in-hospital cardiac arrest (CA) requiring intensive care unit management. Data collection using a standardized form : demographic data and data related to the CA according to the Utstein guidelines.. Circumstances of onset, dates and times of onset and control of abnormal movements (myoclonus and.or seizures). On-scene clinical findings, pre-hospital and hospital care providers, timing of various treatments and supportive care, results of etiological investigations, cause of CA. Dates and times of EEG monitoring, EEG results. Outcomes including vital status and Cerebral Performance Category scale score at ICU and hospital discharge, day-90 and 1-year after CA and determined based on data in the ICU and/or hospital/neurologist charts and/or general practitionner phone interview.

Eligibility Criteria

Inclusion Criteria: * Cardiac arrest requiring Intensive Care Unit management * Age \>= 18 years Exclusion Criteria: \- Refusal to participate

Contact & Investigator

Central Contact

Legriel Stephane, MD

✉ slegriel@ch-versailles.fr
Principal Investigator

Legriel Stephane, MD

STUDY DIRECTOR

Intensive care unit

Frequently Asked Questions

Who can join the NCT03594318 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Arrest. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT03594318 currently recruiting?

Yes, NCT03594318 is actively recruiting participants. Contact the research team at slegriel@ch-versailles.fr for enrollment information.

Where is the NCT03594318 trial being conducted?

This trial is being conducted at Le Chesnay, France.

Who is sponsoring the NCT03594318 clinical trial?

NCT03594318 is sponsored by Versailles Hospital. The principal investigator is Legriel Stephane, MD at Intensive care unit. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology